Tonix Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.76-$672 |
Market Cap | $108M |
Shares Short | 919,908 |
Financials
See moreRevenue (12 Mos) | $10M |
Revenue Growth (YoY) | -31.7% |
Gross Profit (12 Mos) | $2.3M |
Diluted EPS | -$176.60 |
News
See moreYahoo Finance • 12 days ago
Why Tonix Pharmaceuticals Corp. (TNXP) Went Down On Thursday?
Yahoo Finance • 15 days ago
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Yahoo Finance • 29 days ago
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
Yahoo Finance • last month
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
About
CEO | Dr. Seth Lederman M.D. |
CFO | Mr. Bradley Saenger CPA |
Address | 26 Main Street, Chatham, NJ, United States, 07928 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
